There’s still no generic Ozempic, but a lower-priced daily injected GLP-1 is coming
CNN
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced options to reach the market and help address a shortage.
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced options to reach the market and help address a shortage. Liraglutide, sold under the brand name Victoza for diabetes, is an earlier iteration in the same class as semaglutide, the active ingredient in Ozempic. Both are sold by Danish drug giant Novo Nordisk. The generic liraglutide is sold by Hikma Pharmaceuticals USA, and a spokesman told CNN by email that the company expects to make the drug available nationwide before the end of the year. The company didn’t disclose the planned price of the generic, noting only that it “will cost less than branded Victoza.” The branded drug costs between $500 and $815 per package, depending on the dosage, before discounts or insurance, according to Novo Nordisk, which also sells a version of liraglutide approved for obesity, called Saxenda. “There are many people on this drug, and they will benefit by another generic version of it,” Dr. Harlan Krumholz, a cardiologist at Yale University and Yale New Haven Hospital, told CNN by email. But, Krumholz noted, the newer GLP-1 drugs, which are given as weekly injections instead of daily ones, have shown stronger benefits, especially for patients with obesity – and those aren’t yet available as generics.
Run 3 Space | Play Space Running Game
Traffic Jam 3D | Online Racing Game
Duck Hunt | Play Old Classic Game
Falling vaccination rates could lead to the return of previously eliminated diseases, and many more people will be at risk of catching those diseases.
From Madonna to Jack Nicholson, this performance artist attends Paris Fashion Week impersonating some of the world’s most famous celebrities. CNN got a glimpse behind the making of his latest look.
The US Department of Health and Human Services called off an upcoming meeting of expert advisers on preventive health care, raising questions about the future of the longtime nonpolitical advisory group.
An international team of researchers may have just cracked the code for what makes someone “cool.”
After trying to conceive for 18 years, one couple is now pregnant with their first child thanks to the power of artificial intelligence.
Starting July 1, CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed by CVS Caremark.
A tender image of love on Chicago’s lakefront, taken by Doug Ischar, was archived for decades. Now, his 1985 series “Marginal Waters” is being resurfaced in a new exhibit at the MCA Chicago.
After recent moves by the US Department of Health and Human Services to restrict the approval and use of some vaccines — and signs that more changes might be coming — some states and private partnerships are scrambling to ensure that vaccines will still be available to those who want them.